2Ahn SH,Chan HL,Chen PJ, et al. Chronic hepatitis B: whom to treat and for how long ? Propositions, challenges, and future directions[ J]. Hepatot Int,2010, 4( 1 ) :386-395.
3Chen CH,Lu SN,Hung CH, et al. The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment [ J ]. J Hepatol,2014, 61 (3) :515-522.
6Wursthorn K, Jung M, Riva A, et at. Kinetics of Hepatitis B Surface Antigen Decline During 3 Years of Telbivudine Treatment in Hepatitis B e Antigen-Positive Patients[ J]. Hepatology,2010, 52(5 ) : 1611-1620.
7Liang Y, Jiang J, Su M, et al. Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy [ J ]. Aliment Pharmacol Ther,2011,34 ( 3 ) :344-352.
